A significant breakthrough in cancer investigation is occurring with the use of mini-antibodies to re-engage mutated p53. This essential tumor inhibitor protein is frequently inactivated in various types of cancer, https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research